Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Sales, Business Update

Planview Accelerates Growth Momentum in FY'23


Planview, the leading platform for Strategic Portfolio Management (SPM) and Digital Product Development (DPD), announced today record Annual Recurring Revenue (ARR) and billings growth in FY2023, continuing a trend of strong momentum and growth. Planview surpassed $400 million in total Annual Recurring Revenue for 2023.

Fiscal Year End Highlights

Planview achieved record levels for the full fiscal year 2023:

Strong New Logo and Customer Momentum

New or notable customers who selected or expanded their footprint with Planview in 2024 include: Apple Bank, Bausch & Lomb, Cisco Systems, Citibank, Colgate-Palmolive, ConocoPhillips, DANONE, Dexcom, Dr. Reddy's Laboratories, Dyson, Emirates Group, Exact Sciences, Fidelity, Fonterra, Franklin Templeton, GlaxoSmithKline, Ingram Micro, Johnson Controls, Johnson & Johnson, JPMorgan Chase, La Banque Postale, Lam Research, Liberty Mutual Insurance, Lockheed Martin, McKesson, National Grid UK, Novartis, Progressive, Omnicell, Publicis, Qatar National Bank, Regeneron, Schlumberger SIS, Siemens Financial Services, SPX Technologies, Stryker Corporation, Tesco Stores, T-Mobile, TUI InfoTec, University of South Australia, and Vanguard.

Focus on Innovation

Planview's growth is accelerated by the success of its Digital Product Development, Strategic Portfolio Management, and Professional Services Automation solutions. With a focus on driving business outcomes for customers, key innovation milestones over the past year include:

Leading analyst firms continue to recognize Planview, naming the company a leader in several key reports last year, including:

Planview Scales Operations to Support Global Customer-base

With a continued focus on delivering value and support to a more global customer base and scaling up global operations, the company has made strategic hires in key Sales, Customer Services, and Product Development roles, including Data Science, R&D, Partners/Strategic Alliances, Cybersecurity, Business Applications, Professional Services, Managed Services, and Premium Customer Care. In 2023, Planview opened a new global Capability & Innovation Center (CIC) in Bengaluru, India, to drive continued innovation and growth.

Matt Zilli, formerly Planview Chief Revenue Officer, was promoted to President, Field Operations, overseeing all Sales, Alliances, Customer Success, and Services. Driving additional customer outcomes and coordinated growth globally, Planview has also expanded the scope of regional leaders Mike Haugen (Americas), Vishal Dhawan (APAC), and David Stevens (EMEA), to oversee Sales, Customer Success, and Services in those respective markets.

To learn more about Planview visit: www.planview.com. Follow Planview on LinkedIn, Instagram, Twitter, and Facebook.

ABOUT PLANVIEW

Planview has one mission: to build the future of connected work, from ideas to impact. Planview helps organizations accelerate the achievement of what matters most, supporting our customers from need to speed, from passion to progress, and from overhead to optimization. Our connected platform of solutions underpins the business and digital transformations of more than 4,500 customers globally. Planview empowers enterprises to improve time-to-market and predictability, increase efficiency to unlock capacity, and ensure their most strategic initiatives deliver the desired business outcomes.


These press releases may also interest you

at 12:07
IGEL, provider of the secure endpoint OS for now and next, today announced winners of the IGEL Ready Partner of the Year Awards. The award winners were recognized today during the IGEL Ready Summit taking place this week at IGEL DIRUPT 24 in Miami,...

at 12:05
Rebellion Defense, the technology company building software to outpace national security threats, today announced it has been awarded a subcontract for Rebellion Nova to deliver continuous, automated testing for web applications hosted by the U.S....

at 12:05
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic...

at 12:05
Pharmaceutical Strategies Group ("PSG"), an EPIC company, released its annual Trends in Specialty Drug Benefits Report, co-sponsored by Genentech, a member of the Roche Group, detailing the complexities of specialty drug access and affordability. The...

at 12:05
DNB Markets ("DNB") and Back Bay Life Science Advisors ("Back Bay"), acting through the DNB//Back Bay Healthcare Partnership are pleased to announce the dates for our highly anticipated 9th annual Nordic-American Healthcare Conference (NAHC)....

at 12:03
Another successful Vancouver Fashion Week has come to an end. For the FW24 season, the highly anticipated 6-day industry event featured the latest collections from both homegrown and international designers. As a spectacle of diversity, creative...



News published on and distributed by: